CLOCK and pancreatic ductal adenocarcinoma: The examination and evaluation of the circadian clock modulator TH301 as an anti-cancer agent, which are thoroughly described in the present work, have uncovered several promising avenues for the treatment of Pancreatic Ductal Adeno-Carcinoma (PDAC) that, despite strenuous efforts, still remains one of the most lethal malignancies [1].